Asia Pac Allergy.  2015 Jan;5(1):32-39. 10.5415/apallergy.2015.5.1.32.

Reduced severity and improved control of self-reported asthma in Finland during 2001-2010

Affiliations
  • 1Skin and Allergy Hospital, Helsinki University Central Hospital, Helsinki 00250, Finland. paula.kauppi@hus.fi
  • 2Association of Finnish Pharmacies, Helsinki 00500, Finland.
  • 3MedCare Ltd., Äänekoski 44100, Finland.
  • 4The Institute of Healthcare Engineering, Management and Architecture, Aalto 00076, Finland.

Abstract

BACKGROUND
Asthma and allergies are common and cause substantial burden in symptoms and suffering, hospitalizations and medication costs. However, despite the high prevalence, asthma burden has already decreased in Finland in 2000s.
OBJECTIVE
We carried out an asthma barometer survey in all Finnish pharmacies to study changes in asthma severity and control, and use of health care services from 2001 to 2010.
METHODS
Asthma severity, comorbid allergic conditions, and use of medication and health care services were assessed in subjects who purchased asthma or allergy medication from the pharmacies all across the country during one week in 2001 and again in 2010. In 2001, 3,062 patients (mean age, 49 years), and in 2010, 1,114 patients (mean age, 51 years) participated.
RESULTS
In 2001 90% and in 2010 73% of the respondents reported physician-diagnosed asthma and were entitled to special reimbursement for their drug costs, i.e., they needed regular maintenance treatment. In 2001, 10% of the asthmatics regarded their disease as severe, compared with 4% in 2010, while the figures for mild asthma were 45% and 62%, respectively (p < 0.001). The proportion of patients needing emergency care during the last year decreased from 34% (2001) to 14% (2010) (p < 0.001) and the need for hospitalizations from 18% to 6% (p < 0.001). Smoking reduced from 24% to 18% among asthmatics ( p = 0.002). In 2010, risk factors for severe asthma were older age, comorbid atopic eczema, and food allergy.
CONCLUSION
During ten years, self-reported asthma severity has reduced and disease control improved in Finland.

Keyword

Allergy; Drug therapy; Emergency treatment

MeSH Terms

Asthma*
Delivery of Health Care
Dermatitis, Atopic
Drug Costs
Drug Therapy
Emergency Medical Services
Emergency Treatment
Finland*
Food Hypersensitivity
Hospitalization
Humans
Hypersensitivity
Pharmacies
Prevalence
Risk Factors
Smoke
Smoking
Surveys and Questionnaires
Smoke

Figure

  • Fig. 1 Flowchart of the recruitment in 2001 and 2010.

  • Fig. 2 Change of self-reported asthma severity, emergency care (visits) and hospitalizations (hospital days) in Finland 2001 and 2010.


Cited by  2 articles

Asia Pacific allergy: four years of experience
Yoon-Seok Chang
Asia Pac Allergy. 2015;5(1):1-2.    doi: 10.5415/apallergy.2015.5.1.1.

Need for medication and stuffy nose predict the severity of allergic rhinitis
Taneli Salo, Sirpa Peura, Johanna Salimäki, Paula Maasilta, Tari Haahtela, Paula Kauppi
Asia Pac Allergy. 2016;6(2):133-135.    doi: 10.5415/apallergy.2016.6.2.133.


Reference

1. Haahtela T, Laitinen LA. Asthma programme in Finland 1994-2004. Report of a Working Group. Clin Exp Allergy. 1996; 26:Suppl 1. i–ii. 1–24.
2. Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, Nieminen MM, Kontula E, Laitinen LA. A 10 year asthma programme in Finland: major change for the better. Thorax. 2006; 61:663–670.
Article
3. Saynajakangas O, Valmari P, Tuuponen T, Keistinen T. Trends in hospitalization for childhood asthma in Finland in 1996-2004. Acta Paediatr. 2007; 96:919–923.
4. Haahtela T, von Hertzen L, Makela M, Hannuksela M. Allergy Programme Working Group. Finnish Allergy Programme 2008-2018: time to act and change the course. Allergy. 2008; 63:634–645.
5. Klaukka T, Hirvonen A, Peura S, Pakkila H. Asthma treatment in 2001, the essential results of the asthma barometer study. Finnish Med J. 2002; 57:292–294.
6. Plaschke PP, Janson C, Norrman E, Bjornsson E, Ellbjar S, Jarvholm B. Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking. Am J Respir Crit Care Med. 2000; 162(3 Pt 1):920–924.
Article
7. Siroux V, Pin I, Oryszczyn MP, Le Moual N, Kauffmann F. Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the Genetics and Environment of Asthma. Eur Respir J. 2000; 15:470–477.
8. Lee JH, Haselkorn T, Borish L, Rasouliyan L, Chipps BE, Wenzel SE. Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. Chest. 2007; 132:1882–1889.
9. Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol. 2005; 162:764–773.
Article
10. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008; 31:143–178.
Article
11. Pallasaho P, Juusela M, Lindqvist A, Sovijarvi A, Lundback B, Ronmark E. Allergic rhinoconjunctivitis doubles the risk for incident asthma--results from a population study in Helsinki, Finland. Respir Med. 2011; 105:1449–1456.
12. Browatzki A, Ulrik CS, Lange P. Prevalence and severity of self-reported asthma in young adults, 1976-2004. Eur Respir J. 2009; 34:1046–1051.
Article
13. Kauppi P, Linna M, Martikainen J, Makela MJ, Haahtela T. Follow-up of the Finnish Asthma Programme 2000-2010: reduction of hospital burden needs risk group rethinking. Thorax. 2013; 68:292–293.
Article
14. Teppo H, Revonta M, Haahtela T. Allergic rhinitis and asthma have generally good outcome and little effect on quality of life: a 20-year follow-up. Allergy. 2011; 66:1123–1125.
15. Lindstrom I, Suojalehto H, Pallasaho P, Luukkonen R, Karjalainen J, Lauerma A, Karjalainen A. Middle-aged men with asthma since youth: the impact of work on asthma. J Occup Environ Med. 2013; 55:917–923.
16. Bedouch P, Sadatsafavi M, Marra CA, FitzGerald JM, Lynd LD. Trends in asthma-related direct medical costs from 2002 to 2007 in British Columbia, Canada: a population based-cohort study. PLoS One. 2012; 7:e50949.
Article
17. Osborne ML, Pedula KL, O'Hollaren M, Ettinger KM, Stibolt T, Buist AS, Vollmer WM. Assessing future need for acute care in adult asthmatics: the Profile of Asthma Risk Study: a prospective health maintenance organization-based study. Chest. 2007; 132:1151–1161.
18. Polosa R, Thomson NC. Smoking and asthma: dangerous liaisons. Eur Respir J. 2013; 41:716–726.
Article
19. Kauppi P, Kupiainen H, Lindqvist A, Tammilehto L, Kilpelainen M, Kinnula VL, Haahtela T, Laitinen T. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma. 2011; 48:279–285.
Article
20. Tsai CL, Lee WY, Hanania NA, Camargo CA Jr. Age-related differences in clinical outcomes for acute asthma in the United States, 2006-2008. J Allergy Clin Immunol. 2012; 129:1252–1258.e1.
Article
21. Mandelin JM, Remitz A, Virtanen HM, Malmberg LP, Haahtela T, Reitamo S. A 10-year open follow-up of eczema and respiratory symptoms in patients with atopic dermatitis treated with topical tacrolimus for the first 4 years. J Dermatolog Treat. 2010; 21:167–170.
Article
22. Virtanen H, Remitz A, Malmberg P, Rytila P, Metso T, Haahtela T, Reitamo S. Topical tacrolimus in the treatment of atopic dermatitis: does it benefit the airways? A 4-year open follow-up. J Allergy Clin Immunol. 2007; 120:1464–1466.
23. Wang J, Visness CM, Sampson HA. Food allergen sensitization in inner-city children with asthma. J Allergy Clin Immunol. 2005; 115:1076–1080.
Article
24. WHO Collaborating Center for Asthma and Rhinitis. Bousquet J, Anto JM, Demoly P, Schunemann HJ, Togias A, Akdis M, Auffray C, Bachert C, Bieber T, Bousquet PJ, Carlsen KH, Casale TB, Cruz AA, Keil T, Lodrup Carlsen KC, Maurer M, Ohta K, Papadopoulos NG, Roman Rodriguez M, Samolinski B, Agache I, Andrianarisoa A, Ang CS, Annesi-Maesano I, Ballester F, Baena-Cagnani CE, Basagana X, Bateman ED, Bel EH, Bedbrook A, Beghe B, Beji M, Ben Kheder A, Benet M, Bennoor KS, Bergmann KC, Berrissoul F, Bindslev Jensen C, Bleecker ER, Bonini S, Boner AL, Boulet LP, Brightling CE, Brozek JL, Bush A, Busse WW, Camargos PA, Canonica GW, Carr W, Cesario A, Chen YZ, Chiriac AM, Costa DJ, Cox L, Custovic A, Dahl R, Darsow U, Didi T, Dolen WK, Douagui H, Dubakiene R, El-Meziane A, Fonseca JA, Fokkens WJ, Fthenou E, Gamkrelidze A, Garcia-Aymerich J, Gerth van Wijk R, Gimeno-Santos E, Guerra S, Haahtela T, Haddad H, Hellings PW, Hellquist-Dahl B, Hohmann C, Howarth P, Hourihane JO, Humbert M, Jacquemin B, Just J, Kalayci O, Kaliner MA, Kauffmann F, Kerkhof M, Khayat G, Koffi N'Goran B, Kogevinas M, Koppelman GH, Kowalski ML, Kull I, Kuna P, Larenas D, Lavi I, Le LT, Lieberman P, Lipworth B, Mahboub B, Makela MJ, Martin F, Martinez FD, Marshall GD, Mazon A, Melen E, Meltzer EO, Mihaltan F, Mohammad Y, Mohammadi A, Momas I, Morais-Almeida M, Mullol J, Muraro A, Naclerio R, Nafti S, Namazova-Baranova L, Nawijn MC, Nyembue TD, Oddie S, O'Hehir RE, Okamoto Y, Orru MP, Ozdemir C, Ouedraogo GS, Palkonen S, Panzner P, Passalacqua G, Pawankar R, Pigearias B, Pin I, Pinart M, Pison C, Popov TA, Porta D, Postma DS, Price D, Rabe KF, Ratomaharo J, Reitamo S, Rezagui D, Ring J, Roberts R, Roca J, Rogala B, Romano A, Rosado-Pinto J, Ryan D, Sanchez-Borges M, Scadding GK, Sheikh A, Simons FE, Siroux V, Schmid-Grendelmeier PD, Smit HA, Sooronbaev T, Stein RT, Sterk PJ, Sunyer J, Terreehorst I, Toskala E, Tremblay Y, Valenta R, Valeyre D, Vandenplas O, van Weel C, Vassilaki M, Varraso R, Viegi G, Wang DY, Wickman M, Williams D, Wohrl S, Wright J, Yorgancioglu A, Yusuf OM, Zar HJ, Zernotti ME, Zidarn M, Zhong N, Zuberbier T. Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol. 2012; 158:216–231.
Full Text Links
  • APA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr